Last reviewed · How we verify
Platelet Antiaggregant — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Platelet Antiaggregant (Platelet Antiaggregant) — Jaime Daniel Mondragon.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Platelet Antiaggregant TARGET | Platelet Antiaggregant | Jaime Daniel Mondragon | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Platelet Antiaggregant CI watch — RSS
- Platelet Antiaggregant CI watch — Atom
- Platelet Antiaggregant CI watch — JSON
- Platelet Antiaggregant alone — RSS
Cite this brief
Drug Landscape (2026). Platelet Antiaggregant — Competitive Intelligence Brief. https://druglandscape.com/ci/platelet-antiaggregant. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab